Definitive Contract 75N91020C00028
Award Date
9/8/20
Potential Completion Date
6/7/21
Potential Value
$359K
Federal Agency
National Cancer Institute
Awardee
Cellfe, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Carlos, CA 94070, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Celartia, Inc., a small disadvantaged business, for the development of a fully automated system for cell therapy processing. The contract has a period of performance from September 13, 2021 to June 12, 2022 and a ceiling value of $393,312. The contract was awarded under a total small business set-aside. The original...
This Small Business Innovation Research (SBIR) Phase I contract, valued at $399,674, was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Inso Biosciences Inc., a small biotechnology startup. The contract supports the research and development of advanced sample processing platforms for downstream single-cell multi-omic analysis. This work aligns with the NIH and Centers for Disease Control and Prevention (CDC) mission to develop medical...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Micromics Technologies LLC for the development of an "Integrated Platform for In-Depth Single-Cell Proteomics". The contract has a performance period from September 13, 2021 to June 12, 2022 and a ceiling value of $455,000. It is a firm fixed-price definitive contract set aside for small businesses. The original...
This $399,987 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to Care Progress LLC, a small business limited liability company. The contract supports the development of cancer clinical trials recruitment and retention tools for participant engagement, as described in the original SBIR solicitation. The solicitation sought proposals for SBIR Phase I and Phase II contracts to conduct...
This $400,000 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Amplifidx Inc., a woman-owned small business. The contract supports the development of cancer prevention and diagnosis technologies for low-resource settings over a two-year period. This award aligns with NCI's mission to support innovative medical device research and development by small businesses. As a SBIR...
The U.S. National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Celldex Therapeutics, Inc. in the amount of $199,398.00 on September 20, 2012. The contract is for "OTHER FUNCTIONS - R & D BIOMEDICAL (BASIC RESEARCH)" and has a firm fixed price pricing type. The contract has an ultimate completion date of August 23, 2013. This SBIR Phase I award supports basic research and development activities at Celldex Therapeutics, a for-profit small...
This is a $2,049,979.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Proteios Technology, Inc., a self-certified small disadvantaged business. The contract is for the development of a new paradigm for autologous and allogeneic cell therapy manufacturing, based on a previous SBIR Phase I award of $455,000 to the company. This contract was set aside for total small business...
This is a Firm Fixed Price contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Cell Microsystems Inc., a small business manufacturer of tools for imaging, sorting, and isolating single cells and colonies. The $2,295,432.00 contract, which is part of the Small Business Innovation Research (SBIR) program, supports the integration of Cell Microsystems' SCOPE SEQ technology with air flow capabilities for the molecular analysis of glioblastoma, an aggressive...
This definitive contract from the National Institutes of Health's National Cancer Institute, valued at $398,001, was awarded to Ferrologix Inc. to address Topic 397 under a Small Business Innovation Research Program Phase I solicitation. Specifically, the prime contractor will conduct research and development to functionally close the purification and elution of untouched T cells using cleavable magnetic beads with ratcheting cytometry. This firm fixed price contract has a period of...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Synbal, Inc., a small business located in La Costa, California. The contract, valued at $2,300,000.00, is for the "Development and Validation of Non-Mouse Reagents to Enable Preclinical Development of Novel Therapeutics" under the "MOONSHOT" initiative. The contract was set aside for small businesses...